LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 44 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67,905 | -66.2% | 17,191 | -73.2% | 0.00% | – |
Q2 2023 | $200,639 | +93.7% | 64,102 | +180.3% | 0.00% | – |
Q1 2023 | $103,606 | +39144.7% | 22,871 | +35635.9% | 0.00% | – |
Q4 2022 | $264 | – | 64 | +2033.3% | 0.00% | – |
Q3 2022 | $0 | – | 3 | -98.6% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 213 | -99.8% | 0.00% | – |
Q1 2022 | $471,000 | -39.8% | 116,223 | +60.3% | 0.00% | – |
Q4 2021 | $782,000 | -17.2% | 72,510 | -11.4% | 0.00% | – |
Q3 2021 | $944,000 | +1352.3% | 81,810 | +1133.2% | 0.00% | – |
Q2 2021 | $65,000 | -92.5% | 6,634 | -88.9% | 0.00% | – |
Q1 2021 | $872,000 | +1094.5% | 59,700 | +1641.5% | 0.00% | – |
Q4 2020 | $73,000 | -90.2% | 3,428 | -93.0% | 0.00% | – |
Q3 2020 | $744,000 | +2088.2% | 49,047 | +1767.7% | 0.00% | – |
Q2 2020 | $34,000 | – | 2,626 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,746,265 | $12,440,580 | 3.30% |
Opaleye Management Inc. | 1,401,000 | $6,346,530 | 1.90% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $76,744,347 | 1.71% |
GREAT POINT PARTNERS LLC | 900,000 | $4,077,000 | 0.80% |
DAFNA Capital Management LLC | 236,873 | $1,073,035 | 0.32% |
Perceptive Advisors | 2,280,709 | $10,331,612 | 0.30% |
Atlas Venture Advisors, Inc. | 292,184 | $1,323,594 | 0.28% |
MANGROVE PARTNERS IM, LLC | 805,815 | $3,650,342 | 0.24% |
Verition Fund Management LLC | 1,938,822 | $8,782,864 | 0.12% |
Woodline Partners LP | 1,681,913 | $7,619,066 | 0.10% |